| 12.3 |
37.0 |
GO:0097402 |
neuroblast migration(GO:0097402) |
| 10.1 |
30.2 |
GO:0030421 |
defecation(GO:0030421) |
| 9.2 |
27.6 |
GO:0061075 |
cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
| 8.9 |
26.8 |
GO:0002302 |
CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
| 6.2 |
18.6 |
GO:0046022 |
regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 6.2 |
18.5 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 6.1 |
30.4 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 5.8 |
23.4 |
GO:2000974 |
negative regulation of pro-B cell differentiation(GO:2000974) |
| 5.8 |
5.8 |
GO:0070366 |
regulation of hepatocyte differentiation(GO:0070366) |
| 5.6 |
5.6 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 5.3 |
15.8 |
GO:0071898 |
regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
| 5.2 |
10.4 |
GO:0021553 |
olfactory nerve development(GO:0021553) |
| 5.1 |
20.4 |
GO:0060032 |
notochord regression(GO:0060032) |
| 4.9 |
9.8 |
GO:0060857 |
establishment of glial blood-brain barrier(GO:0060857) |
| 4.8 |
29.0 |
GO:0070094 |
positive regulation of glucagon secretion(GO:0070094) |
| 4.8 |
24.1 |
GO:0048382 |
mesendoderm development(GO:0048382) |
| 4.7 |
18.7 |
GO:0072093 |
metanephric renal vesicle formation(GO:0072093) |
| 4.4 |
13.3 |
GO:0060166 |
olfactory pit development(GO:0060166) |
| 4.3 |
4.3 |
GO:1902460 |
regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 4.3 |
12.8 |
GO:0003360 |
brainstem development(GO:0003360) |
| 4.1 |
12.2 |
GO:0097350 |
neutrophil clearance(GO:0097350) |
| 4.0 |
4.0 |
GO:0090194 |
negative regulation of glomerular mesangial cell proliferation(GO:0072125) negative regulation of glomerulus development(GO:0090194) |
| 3.9 |
3.9 |
GO:0045608 |
inhibition of neuroepithelial cell differentiation(GO:0002085) negative regulation of auditory receptor cell differentiation(GO:0045608) |
| 3.9 |
11.6 |
GO:0060598 |
dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
| 3.9 |
15.4 |
GO:1904565 |
response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 3.7 |
7.4 |
GO:2001027 |
negative regulation of endothelial cell chemotaxis(GO:2001027) |
| 3.7 |
11.0 |
GO:0072034 |
renal vesicle induction(GO:0072034) |
| 3.6 |
10.9 |
GO:0060994 |
regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 3.6 |
35.9 |
GO:0021521 |
ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 3.6 |
10.8 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 3.5 |
7.0 |
GO:0003433 |
chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 3.4 |
23.9 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
| 3.3 |
10.0 |
GO:0001869 |
regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 3.3 |
9.8 |
GO:0090187 |
positive regulation of pancreatic juice secretion(GO:0090187) |
| 3.2 |
9.7 |
GO:0061113 |
pancreas morphogenesis(GO:0061113) |
| 3.2 |
9.7 |
GO:0014028 |
notochord formation(GO:0014028) |
| 3.2 |
9.6 |
GO:1990705 |
cholangiocyte proliferation(GO:1990705) |
| 3.2 |
22.4 |
GO:0009449 |
gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 3.2 |
12.7 |
GO:0060838 |
lymphatic endothelial cell fate commitment(GO:0060838) |
| 3.2 |
3.2 |
GO:1903463 |
regulation of mitotic cell cycle DNA replication(GO:1903463) |
| 3.2 |
12.7 |
GO:2000525 |
regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 3.1 |
12.5 |
GO:0014722 |
regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 3.1 |
21.6 |
GO:0021847 |
ventricular zone neuroblast division(GO:0021847) |
| 3.1 |
18.4 |
GO:0048852 |
diencephalon morphogenesis(GO:0048852) |
| 3.0 |
9.1 |
GO:0032877 |
positive regulation of DNA endoreduplication(GO:0032877) |
| 3.0 |
15.2 |
GO:0007223 |
Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 2.9 |
35.1 |
GO:0021978 |
telencephalon regionalization(GO:0021978) |
| 2.9 |
14.5 |
GO:0072513 |
positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 2.8 |
8.4 |
GO:0097212 |
lysosomal membrane organization(GO:0097212) |
| 2.7 |
10.8 |
GO:0015705 |
iodide transport(GO:0015705) |
| 2.7 |
16.1 |
GO:0046985 |
positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 2.7 |
8.0 |
GO:0007494 |
midgut development(GO:0007494) |
| 2.6 |
7.9 |
GO:0072103 |
glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
| 2.6 |
7.9 |
GO:0070634 |
transepithelial ammonium transport(GO:0070634) |
| 2.6 |
7.9 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 2.6 |
13.0 |
GO:1904996 |
positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
| 2.6 |
7.8 |
GO:0061642 |
chemoattraction of axon(GO:0061642) |
| 2.6 |
5.1 |
GO:0072049 |
comma-shaped body morphogenesis(GO:0072049) |
| 2.5 |
7.6 |
GO:0030200 |
heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 2.5 |
7.6 |
GO:0044837 |
assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 2.5 |
7.6 |
GO:0010248 |
B cell negative selection(GO:0002352) establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
| 2.5 |
5.0 |
GO:0072095 |
regulation of branch elongation involved in ureteric bud branching(GO:0072095) |
| 2.5 |
10.0 |
GO:2001045 |
negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 2.5 |
27.6 |
GO:0006105 |
succinate metabolic process(GO:0006105) |
| 2.5 |
5.0 |
GO:0072236 |
metanephric loop of Henle development(GO:0072236) |
| 2.4 |
7.3 |
GO:1904020 |
regulation of G-protein coupled receptor internalization(GO:1904020) |
| 2.4 |
23.6 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 2.3 |
7.0 |
GO:0072137 |
condensed mesenchymal cell proliferation(GO:0072137) |
| 2.3 |
9.1 |
GO:0007056 |
spindle assembly involved in female meiosis(GO:0007056) |
| 2.3 |
4.5 |
GO:0060591 |
chondroblast differentiation(GO:0060591) |
| 2.3 |
6.8 |
GO:0019343 |
cysteine biosynthetic process via cystathionine(GO:0019343) cysteine biosynthetic process(GO:0019344) |
| 2.2 |
31.2 |
GO:0014841 |
skeletal muscle satellite cell proliferation(GO:0014841) |
| 2.2 |
2.2 |
GO:1904672 |
regulation of somatic stem cell population maintenance(GO:1904672) |
| 2.2 |
4.4 |
GO:0061054 |
dermatome development(GO:0061054) regulation of dermatome development(GO:0061183) |
| 2.2 |
8.7 |
GO:0048318 |
axial mesoderm development(GO:0048318) |
| 2.2 |
15.1 |
GO:0072257 |
metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
| 2.2 |
8.6 |
GO:0030091 |
protein repair(GO:0030091) |
| 2.1 |
21.4 |
GO:0032776 |
DNA methylation on cytosine(GO:0032776) |
| 2.1 |
4.2 |
GO:1902913 |
positive regulation of melanocyte differentiation(GO:0045636) positive regulation of developmental pigmentation(GO:0048087) positive regulation of pigment cell differentiation(GO:0050942) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
| 2.1 |
44.1 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 2.1 |
10.4 |
GO:0098912 |
membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) |
| 2.1 |
20.6 |
GO:2000781 |
positive regulation of double-strand break repair(GO:2000781) |
| 2.1 |
8.2 |
GO:0006244 |
pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 2.0 |
16.3 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 2.0 |
10.1 |
GO:0044806 |
G-quadruplex DNA unwinding(GO:0044806) |
| 2.0 |
6.0 |
GO:0021764 |
amygdala development(GO:0021764) |
| 2.0 |
4.0 |
GO:0021759 |
globus pallidus development(GO:0021759) |
| 2.0 |
8.0 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 2.0 |
4.0 |
GO:0072223 |
metanephric glomerular mesangium development(GO:0072223) metanephric glomerular mesangial cell proliferation involved in metanephros development(GO:0072262) |
| 2.0 |
5.9 |
GO:0042732 |
D-xylose metabolic process(GO:0042732) |
| 2.0 |
5.9 |
GO:0003245 |
cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 2.0 |
7.8 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 1.9 |
13.5 |
GO:1904627 |
response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
| 1.9 |
11.5 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 1.9 |
17.2 |
GO:0060501 |
positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
| 1.9 |
9.5 |
GO:1900170 |
negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
| 1.9 |
3.8 |
GO:0021529 |
spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 1.9 |
1.9 |
GO:0021603 |
cranial nerve formation(GO:0021603) |
| 1.9 |
20.6 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 1.9 |
3.8 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) |
| 1.9 |
15.0 |
GO:0097421 |
liver regeneration(GO:0097421) |
| 1.9 |
18.6 |
GO:2000675 |
negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 1.9 |
1.9 |
GO:0007352 |
zygotic specification of dorsal/ventral axis(GO:0007352) |
| 1.8 |
5.5 |
GO:0071579 |
regulation of zinc ion transport(GO:0071579) |
| 1.8 |
5.5 |
GO:0045819 |
plasmacytoid dendritic cell activation(GO:0002270) positive regulation of glycogen catabolic process(GO:0045819) |
| 1.8 |
7.4 |
GO:0006447 |
regulation of translational initiation by iron(GO:0006447) positive regulation of translational initiation by iron(GO:0045994) |
| 1.8 |
5.5 |
GO:0014834 |
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
| 1.8 |
9.2 |
GO:0035022 |
positive regulation of Rac protein signal transduction(GO:0035022) |
| 1.8 |
9.1 |
GO:0048706 |
embryonic skeletal system development(GO:0048706) |
| 1.8 |
19.6 |
GO:0061302 |
smooth muscle cell-matrix adhesion(GO:0061302) |
| 1.8 |
5.3 |
GO:1902162 |
regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) |
| 1.7 |
7.0 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 1.7 |
10.4 |
GO:0044351 |
macropinocytosis(GO:0044351) |
| 1.7 |
5.2 |
GO:0051124 |
synaptic growth at neuromuscular junction(GO:0051124) |
| 1.7 |
5.1 |
GO:0060489 |
orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 1.7 |
3.4 |
GO:0009583 |
detection of light stimulus(GO:0009583) |
| 1.7 |
15.4 |
GO:0010216 |
maintenance of DNA methylation(GO:0010216) |
| 1.7 |
13.5 |
GO:2001198 |
regulation of dendritic cell differentiation(GO:2001198) |
| 1.7 |
5.1 |
GO:0007262 |
STAT protein import into nucleus(GO:0007262) |
| 1.7 |
1.7 |
GO:0090080 |
positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 1.7 |
6.7 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 1.7 |
6.7 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 1.7 |
9.9 |
GO:0002072 |
optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
| 1.6 |
6.6 |
GO:1902037 |
negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
| 1.6 |
6.5 |
GO:0032053 |
ciliary basal body organization(GO:0032053) |
| 1.6 |
3.3 |
GO:0003263 |
cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) |
| 1.6 |
6.5 |
GO:0010668 |
ectodermal cell differentiation(GO:0010668) |
| 1.6 |
1.6 |
GO:0032817 |
regulation of natural killer cell proliferation(GO:0032817) positive regulation of natural killer cell proliferation(GO:0032819) |
| 1.6 |
8.1 |
GO:0097368 |
establishment of Sertoli cell barrier(GO:0097368) |
| 1.6 |
6.5 |
GO:0060842 |
arterial endothelial cell differentiation(GO:0060842) |
| 1.6 |
1.6 |
GO:1902263 |
apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
| 1.6 |
3.2 |
GO:0007228 |
positive regulation of hh target transcription factor activity(GO:0007228) |
| 1.6 |
6.3 |
GO:2001032 |
regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 1.6 |
4.7 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 1.6 |
15.7 |
GO:0071481 |
cellular response to X-ray(GO:0071481) |
| 1.6 |
9.4 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 1.6 |
4.7 |
GO:1901420 |
negative regulation of response to alcohol(GO:1901420) |
| 1.5 |
1.5 |
GO:0009880 |
embryonic pattern specification(GO:0009880) |
| 1.5 |
4.6 |
GO:0070315 |
G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 1.5 |
4.6 |
GO:1903048 |
regulation of acetylcholine-gated cation channel activity(GO:1903048) |
| 1.5 |
6.1 |
GO:1900109 |
regulation of histone H3-K9 dimethylation(GO:1900109) |
| 1.5 |
3.0 |
GO:0006083 |
acetate metabolic process(GO:0006083) |
| 1.5 |
1.5 |
GO:2000373 |
regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
| 1.5 |
4.5 |
GO:0006116 |
NADH oxidation(GO:0006116) |
| 1.5 |
4.5 |
GO:0045578 |
negative regulation of B cell differentiation(GO:0045578) |
| 1.5 |
7.5 |
GO:2000427 |
positive regulation of apoptotic cell clearance(GO:2000427) |
| 1.5 |
9.0 |
GO:0045198 |
establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 1.5 |
1.5 |
GO:0002063 |
chondrocyte development(GO:0002063) |
| 1.5 |
3.0 |
GO:0002572 |
pro-T cell differentiation(GO:0002572) |
| 1.5 |
1.5 |
GO:1903490 |
regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 1.5 |
8.9 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 1.5 |
1.5 |
GO:0042440 |
pigment metabolic process(GO:0042440) |
| 1.5 |
10.3 |
GO:1903753 |
negative regulation of p38MAPK cascade(GO:1903753) |
| 1.5 |
4.4 |
GO:0034334 |
adherens junction maintenance(GO:0034334) |
| 1.5 |
8.8 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 1.5 |
5.8 |
GO:0032901 |
positive regulation of neurotrophin production(GO:0032901) |
| 1.5 |
4.4 |
GO:0019405 |
alditol catabolic process(GO:0019405) |
| 1.5 |
5.8 |
GO:0035426 |
extracellular matrix-cell signaling(GO:0035426) |
| 1.4 |
13.0 |
GO:0072189 |
ureter development(GO:0072189) |
| 1.4 |
4.3 |
GO:1904719 |
excitatory chemical synaptic transmission(GO:0098976) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 1.4 |
30.0 |
GO:0050434 |
positive regulation of viral transcription(GO:0050434) |
| 1.4 |
1.4 |
GO:0036118 |
hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 1.4 |
2.9 |
GO:0023016 |
signal transduction by trans-phosphorylation(GO:0023016) |
| 1.4 |
2.8 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 1.4 |
22.7 |
GO:0071459 |
protein localization to chromosome, centromeric region(GO:0071459) |
| 1.4 |
8.5 |
GO:0070307 |
lens fiber cell development(GO:0070307) |
| 1.4 |
1.4 |
GO:0072235 |
distal convoluted tubule development(GO:0072025) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) |
| 1.4 |
11.2 |
GO:0010587 |
miRNA catabolic process(GO:0010587) |
| 1.4 |
5.6 |
GO:0034770 |
histone H4-K20 methylation(GO:0034770) |
| 1.4 |
1.4 |
GO:0003104 |
positive regulation of glomerular filtration(GO:0003104) |
| 1.4 |
1.4 |
GO:0070172 |
positive regulation of tooth mineralization(GO:0070172) |
| 1.4 |
8.4 |
GO:0035413 |
positive regulation of catenin import into nucleus(GO:0035413) |
| 1.4 |
15.3 |
GO:0072539 |
T-helper 17 cell differentiation(GO:0072539) |
| 1.4 |
2.8 |
GO:0090129 |
positive regulation of synapse maturation(GO:0090129) |
| 1.4 |
5.5 |
GO:0006663 |
platelet activating factor biosynthetic process(GO:0006663) |
| 1.4 |
9.6 |
GO:0001842 |
neural fold formation(GO:0001842) |
| 1.4 |
1.4 |
GO:0060900 |
embryonic camera-type eye formation(GO:0060900) |
| 1.4 |
8.2 |
GO:1904936 |
cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 1.4 |
12.3 |
GO:0098700 |
neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 1.4 |
6.8 |
GO:0021914 |
smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021910) negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
| 1.4 |
4.1 |
GO:0051660 |
establishment of centrosome localization(GO:0051660) |
| 1.3 |
4.0 |
GO:1902566 |
regulation of eosinophil activation(GO:1902566) |
| 1.3 |
6.7 |
GO:0043922 |
negative regulation by host of viral transcription(GO:0043922) |
| 1.3 |
12.1 |
GO:0070874 |
negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 1.3 |
4.0 |
GO:0019323 |
pentose catabolic process(GO:0019323) |
| 1.3 |
1.3 |
GO:0006103 |
2-oxoglutarate metabolic process(GO:0006103) |
| 1.3 |
9.3 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 1.3 |
3.9 |
GO:0016554 |
cytidine to uridine editing(GO:0016554) |
| 1.3 |
3.9 |
GO:0019230 |
proprioception(GO:0019230) |
| 1.3 |
11.7 |
GO:0042573 |
retinoic acid metabolic process(GO:0042573) |
| 1.3 |
9.1 |
GO:0043586 |
tongue development(GO:0043586) |
| 1.3 |
3.9 |
GO:0071918 |
urea transmembrane transport(GO:0071918) |
| 1.3 |
2.5 |
GO:0061430 |
bone trabecula morphogenesis(GO:0061430) |
| 1.3 |
1.3 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 1.3 |
2.5 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 1.3 |
5.1 |
GO:0070269 |
pyroptosis(GO:0070269) |
| 1.3 |
3.8 |
GO:2001160 |
regulation of histone H3-K79 methylation(GO:2001160) |
| 1.2 |
8.7 |
GO:0072070 |
loop of Henle development(GO:0072070) |
| 1.2 |
3.7 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 1.2 |
2.5 |
GO:0060059 |
embryonic retina morphogenesis in camera-type eye(GO:0060059) |
| 1.2 |
3.7 |
GO:2000297 |
negative regulation of synapse maturation(GO:2000297) |
| 1.2 |
3.7 |
GO:0006661 |
phosphatidylinositol biosynthetic process(GO:0006661) |
| 1.2 |
2.4 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 1.2 |
2.4 |
GO:2000096 |
positive regulation of non-canonical Wnt signaling pathway(GO:2000052) regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 1.2 |
1.2 |
GO:0016445 |
somatic diversification of immunoglobulins(GO:0016445) |
| 1.2 |
2.4 |
GO:0060391 |
positive regulation of SMAD protein import into nucleus(GO:0060391) |
| 1.2 |
2.4 |
GO:0042074 |
cell migration involved in gastrulation(GO:0042074) |
| 1.2 |
7.1 |
GO:2001269 |
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
| 1.2 |
22.4 |
GO:0006978 |
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
| 1.2 |
21.1 |
GO:0001779 |
natural killer cell differentiation(GO:0001779) |
| 1.2 |
2.3 |
GO:0043415 |
positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
| 1.2 |
5.8 |
GO:0031580 |
membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 1.2 |
8.1 |
GO:0015670 |
carbon dioxide transport(GO:0015670) |
| 1.2 |
4.6 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 1.2 |
1.2 |
GO:0060037 |
pharyngeal system development(GO:0060037) |
| 1.2 |
5.8 |
GO:1904690 |
regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 1.1 |
1.1 |
GO:0007113 |
endomitotic cell cycle(GO:0007113) |
| 1.1 |
1.1 |
GO:0003415 |
chondrocyte hypertrophy(GO:0003415) |
| 1.1 |
3.4 |
GO:0044778 |
meiotic DNA integrity checkpoint(GO:0044778) |
| 1.1 |
1.1 |
GO:0060282 |
positive regulation of oocyte development(GO:0060282) |
| 1.1 |
7.9 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 1.1 |
3.4 |
GO:0090136 |
epithelial cell-cell adhesion(GO:0090136) |
| 1.1 |
7.9 |
GO:1901970 |
positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
| 1.1 |
4.5 |
GO:2001274 |
negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
| 1.1 |
8.9 |
GO:0000395 |
mRNA 5'-splice site recognition(GO:0000395) |
| 1.1 |
11.1 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 1.1 |
5.5 |
GO:0001561 |
fatty acid alpha-oxidation(GO:0001561) |
| 1.1 |
4.4 |
GO:0042730 |
fibrinolysis(GO:0042730) |
| 1.1 |
5.5 |
GO:0036123 |
histone H3-K9 dimethylation(GO:0036123) |
| 1.1 |
8.8 |
GO:0048617 |
embryonic foregut morphogenesis(GO:0048617) |
| 1.1 |
2.2 |
GO:0036292 |
DNA rewinding(GO:0036292) |
| 1.1 |
4.4 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 1.1 |
11.0 |
GO:0032876 |
negative regulation of DNA endoreduplication(GO:0032876) |
| 1.1 |
6.6 |
GO:1904948 |
midbrain dopaminergic neuron differentiation(GO:1904948) |
| 1.1 |
4.4 |
GO:0006982 |
response to lipid hydroperoxide(GO:0006982) cellular response to lipid hydroperoxide(GO:0071449) |
| 1.1 |
3.3 |
GO:0090271 |
positive regulation of fibroblast growth factor production(GO:0090271) |
| 1.1 |
1.1 |
GO:1905048 |
regulation of metallopeptidase activity(GO:1905048) |
| 1.1 |
7.6 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 1.1 |
7.5 |
GO:0035735 |
intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 1.1 |
12.8 |
GO:1902459 |
positive regulation of stem cell population maintenance(GO:1902459) |
| 1.1 |
2.1 |
GO:0061299 |
retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 1.1 |
7.4 |
GO:0033567 |
DNA replication, Okazaki fragment processing(GO:0033567) |
| 1.1 |
1.1 |
GO:0030167 |
proteoglycan catabolic process(GO:0030167) |
| 1.1 |
2.1 |
GO:0070671 |
response to interleukin-12(GO:0070671) |
| 1.1 |
5.3 |
GO:0098706 |
ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
| 1.1 |
5.3 |
GO:0035469 |
determination of pancreatic left/right asymmetry(GO:0035469) |
| 1.1 |
3.2 |
GO:0010847 |
regulation of chromatin assembly(GO:0010847) |
| 1.0 |
3.1 |
GO:0034241 |
positive regulation of macrophage fusion(GO:0034241) |
| 1.0 |
2.1 |
GO:0044340 |
canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
| 1.0 |
10.4 |
GO:0031441 |
negative regulation of mRNA 3'-end processing(GO:0031441) |
| 1.0 |
2.1 |
GO:1900377 |
negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
| 1.0 |
1.0 |
GO:0061298 |
retina vasculature development in camera-type eye(GO:0061298) |
| 1.0 |
2.1 |
GO:0090118 |
receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 1.0 |
4.1 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 1.0 |
2.0 |
GO:0060687 |
regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
| 1.0 |
3.0 |
GO:0052428 |
modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 1.0 |
7.1 |
GO:0048596 |
embryonic camera-type eye morphogenesis(GO:0048596) |
| 1.0 |
4.0 |
GO:0015889 |
cobalamin transport(GO:0015889) |
| 1.0 |
3.0 |
GO:1902528 |
regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 1.0 |
3.0 |
GO:0060821 |
inactivation of X chromosome by DNA methylation(GO:0060821) |
| 1.0 |
3.0 |
GO:2000053 |
regulation of chondrocyte development(GO:0061181) regulation of centromeric sister chromatid cohesion(GO:0070602) regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) |
| 1.0 |
3.9 |
GO:0007096 |
regulation of exit from mitosis(GO:0007096) |
| 1.0 |
3.9 |
GO:0001880 |
Mullerian duct regression(GO:0001880) |
| 1.0 |
1.0 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 1.0 |
8.8 |
GO:0035428 |
hexose transmembrane transport(GO:0035428) |
| 1.0 |
4.9 |
GO:0089700 |
protein kinase D signaling(GO:0089700) |
| 1.0 |
22.4 |
GO:1902043 |
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 1.0 |
4.9 |
GO:0097152 |
mesenchymal cell apoptotic process(GO:0097152) |
| 1.0 |
2.9 |
GO:0006553 |
lysine metabolic process(GO:0006553) |
| 1.0 |
4.8 |
GO:0048368 |
lateral mesoderm development(GO:0048368) |
| 1.0 |
3.8 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.9 |
5.7 |
GO:0009950 |
dorsal/ventral axis specification(GO:0009950) |
| 0.9 |
9.4 |
GO:0043567 |
regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.9 |
3.7 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.9 |
1.9 |
GO:0035989 |
tendon development(GO:0035989) |
| 0.9 |
2.8 |
GO:1903519 |
apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 0.9 |
0.9 |
GO:1902869 |
regulation of amacrine cell differentiation(GO:1902869) |
| 0.9 |
6.5 |
GO:0046643 |
regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
| 0.9 |
0.9 |
GO:0060762 |
regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.9 |
3.7 |
GO:0006659 |
phosphatidylserine biosynthetic process(GO:0006659) |
| 0.9 |
2.8 |
GO:0086053 |
AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 0.9 |
2.8 |
GO:1903070 |
negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.9 |
4.6 |
GO:0032298 |
positive regulation of DNA-dependent DNA replication initiation(GO:0032298) |
| 0.9 |
1.8 |
GO:0010757 |
negative regulation of plasminogen activation(GO:0010757) |
| 0.9 |
1.8 |
GO:1904706 |
negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.9 |
16.4 |
GO:0032461 |
positive regulation of protein oligomerization(GO:0032461) |
| 0.9 |
6.4 |
GO:0051256 |
mitotic spindle midzone assembly(GO:0051256) |
| 0.9 |
0.9 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
| 0.9 |
1.8 |
GO:0034137 |
positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
| 0.9 |
2.7 |
GO:1902990 |
mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
| 0.9 |
3.6 |
GO:0015867 |
ATP transport(GO:0015867) |
| 0.9 |
1.8 |
GO:0009814 |
defense response, incompatible interaction(GO:0009814) |
| 0.9 |
3.5 |
GO:0033085 |
negative regulation of T cell differentiation in thymus(GO:0033085) |
| 0.9 |
3.5 |
GO:2001137 |
positive regulation of endocytic recycling(GO:2001137) |
| 0.9 |
2.6 |
GO:0006285 |
base-excision repair, AP site formation(GO:0006285) |
| 0.9 |
2.6 |
GO:0048633 |
positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 0.9 |
1.8 |
GO:0043921 |
modulation by host of viral transcription(GO:0043921) modulation of transcription in other organism involved in symbiotic interaction(GO:0052312) modulation by host of symbiont transcription(GO:0052472) |
| 0.9 |
2.6 |
GO:0048105 |
establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
| 0.9 |
5.2 |
GO:0060754 |
positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.9 |
1.7 |
GO:0045736 |
negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
| 0.9 |
4.3 |
GO:1903609 |
negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
| 0.9 |
6.0 |
GO:1903689 |
regulation of wound healing, spreading of epidermal cells(GO:1903689) |
| 0.9 |
8.6 |
GO:0043374 |
CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.9 |
3.4 |
GO:0070829 |
heterochromatin maintenance(GO:0070829) |
| 0.9 |
2.6 |
GO:0019659 |
fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
| 0.9 |
5.1 |
GO:0003383 |
apical constriction(GO:0003383) |
| 0.8 |
5.1 |
GO:0045654 |
positive regulation of megakaryocyte differentiation(GO:0045654) |
| 0.8 |
4.2 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.8 |
1.7 |
GO:1902915 |
negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.8 |
1.7 |
GO:0032332 |
positive regulation of chondrocyte differentiation(GO:0032332) |
| 0.8 |
0.8 |
GO:0018298 |
protein-chromophore linkage(GO:0018298) |
| 0.8 |
4.2 |
GO:0003420 |
regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
| 0.8 |
2.5 |
GO:0006578 |
amino-acid betaine biosynthetic process(GO:0006578) |
| 0.8 |
1.6 |
GO:0071364 |
cellular response to epidermal growth factor stimulus(GO:0071364) |
| 0.8 |
6.5 |
GO:0070236 |
negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.8 |
4.1 |
GO:0038030 |
non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.8 |
1.6 |
GO:0061357 |
Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) positive regulation of Wnt protein secretion(GO:0061357) |
| 0.8 |
6.5 |
GO:0002315 |
marginal zone B cell differentiation(GO:0002315) |
| 0.8 |
0.8 |
GO:0033128 |
negative regulation of histone phosphorylation(GO:0033128) |
| 0.8 |
3.2 |
GO:0021780 |
oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
| 0.8 |
2.3 |
GO:0036462 |
TRAIL-activated apoptotic signaling pathway(GO:0036462) |
| 0.8 |
3.9 |
GO:0043383 |
negative T cell selection(GO:0043383) negative thymic T cell selection(GO:0045060) |
| 0.8 |
3.1 |
GO:0060272 |
embryonic skeletal joint morphogenesis(GO:0060272) |
| 0.8 |
3.1 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.8 |
8.5 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.8 |
6.2 |
GO:0000056 |
ribosomal small subunit export from nucleus(GO:0000056) |
| 0.8 |
3.8 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 0.8 |
0.8 |
GO:0032916 |
transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) positive regulation of transforming growth factor beta3 production(GO:0032916) |
| 0.8 |
0.8 |
GO:2001013 |
epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.8 |
8.4 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.8 |
3.0 |
GO:0048664 |
neuron fate determination(GO:0048664) |
| 0.8 |
3.8 |
GO:0051026 |
chiasma assembly(GO:0051026) |
| 0.8 |
2.3 |
GO:1990859 |
cellular response to endothelin(GO:1990859) |
| 0.8 |
0.8 |
GO:0051315 |
attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
| 0.7 |
1.5 |
GO:0090274 |
positive regulation of somatostatin secretion(GO:0090274) |
| 0.7 |
1.5 |
GO:1901355 |
response to rapamycin(GO:1901355) |
| 0.7 |
7.5 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.7 |
4.5 |
GO:0009071 |
serine family amino acid catabolic process(GO:0009071) |
| 0.7 |
0.7 |
GO:0051893 |
regulation of focal adhesion assembly(GO:0051893) regulation of cell-substrate junction assembly(GO:0090109) regulation of cell junction assembly(GO:1901888) |
| 0.7 |
5.9 |
GO:0040031 |
snRNA modification(GO:0040031) |
| 0.7 |
4.4 |
GO:0070836 |
caveola assembly(GO:0070836) |
| 0.7 |
4.4 |
GO:0034080 |
CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.7 |
1.5 |
GO:0072202 |
cell differentiation involved in metanephros development(GO:0072202) |
| 0.7 |
2.2 |
GO:0051661 |
maintenance of centrosome location(GO:0051661) |
| 0.7 |
6.5 |
GO:0048934 |
peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.7 |
24.6 |
GO:0051310 |
metaphase plate congression(GO:0051310) |
| 0.7 |
2.2 |
GO:0060903 |
positive regulation of meiosis I(GO:0060903) |
| 0.7 |
1.4 |
GO:1904245 |
regulation of polynucleotide adenylyltransferase activity(GO:1904245) |
| 0.7 |
2.8 |
GO:0018076 |
N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.7 |
2.1 |
GO:1903644 |
regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.7 |
4.2 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.7 |
1.4 |
GO:0007161 |
calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.7 |
2.8 |
GO:0034219 |
carbohydrate transmembrane transport(GO:0034219) |
| 0.7 |
4.2 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.7 |
4.9 |
GO:0010273 |
detoxification of copper ion(GO:0010273) detoxification of inorganic compound(GO:0061687) stress response to copper ion(GO:1990169) |
| 0.7 |
0.7 |
GO:0000720 |
pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
| 0.7 |
5.5 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 0.7 |
1.4 |
GO:0007140 |
male meiosis(GO:0007140) |
| 0.7 |
4.1 |
GO:0018401 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.7 |
6.9 |
GO:0045603 |
positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.7 |
2.7 |
GO:2001286 |
regulation of caveolin-mediated endocytosis(GO:2001286) |
| 0.7 |
1.4 |
GO:0097527 |
necroptotic signaling pathway(GO:0097527) |
| 0.7 |
3.4 |
GO:0046666 |
retinal cell programmed cell death(GO:0046666) |
| 0.7 |
12.2 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
| 0.7 |
1.4 |
GO:0060579 |
ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
| 0.7 |
1.4 |
GO:2001014 |
regulation of skeletal muscle cell differentiation(GO:2001014) |
| 0.7 |
0.7 |
GO:0060689 |
cell differentiation involved in salivary gland development(GO:0060689) |
| 0.7 |
12.8 |
GO:0030866 |
cortical actin cytoskeleton organization(GO:0030866) |
| 0.7 |
9.4 |
GO:0040034 |
regulation of development, heterochronic(GO:0040034) |
| 0.7 |
2.0 |
GO:0010641 |
positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
| 0.7 |
2.0 |
GO:0019441 |
tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) kynurenine metabolic process(GO:0070189) |
| 0.7 |
2.0 |
GO:0030222 |
eosinophil differentiation(GO:0030222) |
| 0.7 |
4.0 |
GO:0014054 |
positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
| 0.7 |
3.3 |
GO:0072675 |
multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 0.7 |
0.7 |
GO:0033083 |
immature T cell proliferation(GO:0033079) regulation of immature T cell proliferation(GO:0033083) |
| 0.7 |
2.0 |
GO:0030202 |
heparin metabolic process(GO:0030202) |
| 0.7 |
8.5 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 0.7 |
3.3 |
GO:1901860 |
positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
| 0.7 |
2.0 |
GO:0045876 |
positive regulation of sister chromatid cohesion(GO:0045876) |
| 0.7 |
21.5 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.7 |
2.0 |
GO:0045799 |
positive regulation of chromatin assembly or disassembly(GO:0045799) |
| 0.7 |
0.7 |
GO:0060242 |
contact inhibition(GO:0060242) |
| 0.6 |
5.2 |
GO:0031086 |
nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) |
| 0.6 |
10.4 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.6 |
1.3 |
GO:0007044 |
cell-substrate junction assembly(GO:0007044) |
| 0.6 |
1.3 |
GO:0046835 |
carbohydrate phosphorylation(GO:0046835) |
| 0.6 |
4.5 |
GO:0006971 |
hypotonic response(GO:0006971) |
| 0.6 |
3.2 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.6 |
1.3 |
GO:0098727 |
maintenance of cell number(GO:0098727) |
| 0.6 |
1.9 |
GO:0009446 |
putrescine biosynthetic process(GO:0009446) |
| 0.6 |
3.2 |
GO:0034421 |
post-translational protein acetylation(GO:0034421) |
| 0.6 |
5.7 |
GO:0010766 |
negative regulation of sodium ion transport(GO:0010766) |
| 0.6 |
3.2 |
GO:0001711 |
endodermal cell fate commitment(GO:0001711) |
| 0.6 |
3.2 |
GO:0006167 |
AMP biosynthetic process(GO:0006167) |
| 0.6 |
2.5 |
GO:0006346 |
methylation-dependent chromatin silencing(GO:0006346) |
| 0.6 |
1.9 |
GO:0042097 |
interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
| 0.6 |
4.4 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.6 |
2.5 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.6 |
1.3 |
GO:0006059 |
hexitol metabolic process(GO:0006059) |
| 0.6 |
3.1 |
GO:0098914 |
membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
| 0.6 |
6.3 |
GO:0021924 |
cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
| 0.6 |
3.1 |
GO:0090234 |
regulation of kinetochore assembly(GO:0090234) |
| 0.6 |
3.1 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.6 |
2.5 |
GO:0010626 |
negative regulation of Schwann cell proliferation(GO:0010626) |
| 0.6 |
1.2 |
GO:0071707 |
immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
| 0.6 |
1.9 |
GO:0048016 |
inositol phosphate-mediated signaling(GO:0048016) |
| 0.6 |
11.7 |
GO:0032467 |
positive regulation of cytokinesis(GO:0032467) |
| 0.6 |
2.5 |
GO:0044342 |
type B pancreatic cell proliferation(GO:0044342) |
| 0.6 |
4.9 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.6 |
7.4 |
GO:0048199 |
vesicle targeting, to, from or within Golgi(GO:0048199) |
| 0.6 |
6.1 |
GO:1903504 |
regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.6 |
15.3 |
GO:0021915 |
neural tube development(GO:0021915) |
| 0.6 |
2.4 |
GO:0046947 |
hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.6 |
1.2 |
GO:0060923 |
muscle cell fate commitment(GO:0042693) cardiac muscle cell fate commitment(GO:0060923) |
| 0.6 |
3.0 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 0.6 |
3.0 |
GO:0042256 |
mature ribosome assembly(GO:0042256) |
| 0.6 |
0.6 |
GO:0070873 |
regulation of glycogen metabolic process(GO:0070873) |
| 0.6 |
0.6 |
GO:0016332 |
establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
| 0.6 |
1.2 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 0.6 |
5.4 |
GO:0061158 |
3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.6 |
13.8 |
GO:0045880 |
positive regulation of smoothened signaling pathway(GO:0045880) |
| 0.6 |
7.8 |
GO:0007530 |
sex determination(GO:0007530) |
| 0.6 |
0.6 |
GO:0010172 |
embryonic body morphogenesis(GO:0010172) |
| 0.6 |
2.4 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 0.6 |
0.6 |
GO:0071500 |
cellular response to nitrosative stress(GO:0071500) |
| 0.6 |
2.4 |
GO:0051387 |
negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
| 0.6 |
1.8 |
GO:0033566 |
gamma-tubulin complex localization(GO:0033566) |
| 0.6 |
2.3 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.6 |
0.6 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.6 |
1.2 |
GO:0034196 |
acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.6 |
5.8 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.6 |
12.2 |
GO:0000289 |
nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.6 |
1.2 |
GO:0042976 |
activation of Janus kinase activity(GO:0042976) |
| 0.6 |
2.9 |
GO:0072584 |
caveolin-mediated endocytosis(GO:0072584) |
| 0.6 |
3.5 |
GO:0043584 |
nose development(GO:0043584) |
| 0.6 |
1.7 |
GO:0070844 |
misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 0.6 |
2.3 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 0.6 |
4.0 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.6 |
2.3 |
GO:0045163 |
clustering of voltage-gated potassium channels(GO:0045163) |
| 0.6 |
4.5 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.6 |
1.1 |
GO:0030208 |
dermatan sulfate biosynthetic process(GO:0030208) |
| 0.6 |
3.3 |
GO:0031665 |
negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.6 |
1.1 |
GO:0003180 |
aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
| 0.6 |
1.7 |
GO:0015840 |
urea transport(GO:0015840) |
| 0.6 |
1.7 |
GO:0042560 |
10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 0.6 |
2.8 |
GO:0045918 |
negative regulation of cytolysis(GO:0045918) |
| 0.6 |
0.6 |
GO:0044339 |
canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.5 |
2.7 |
GO:0046459 |
short-chain fatty acid metabolic process(GO:0046459) |
| 0.5 |
3.3 |
GO:0085020 |
protein K6-linked ubiquitination(GO:0085020) |
| 0.5 |
2.2 |
GO:0070318 |
positive regulation of G0 to G1 transition(GO:0070318) |
| 0.5 |
2.2 |
GO:0031508 |
pericentric heterochromatin assembly(GO:0031508) |
| 0.5 |
1.6 |
GO:0046655 |
folic acid metabolic process(GO:0046655) |
| 0.5 |
1.6 |
GO:1901052 |
sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 0.5 |
0.5 |
GO:0003357 |
noradrenergic neuron differentiation(GO:0003357) |
| 0.5 |
2.2 |
GO:0046061 |
dATP catabolic process(GO:0046061) |
| 0.5 |
1.6 |
GO:0061743 |
motor learning(GO:0061743) |
| 0.5 |
1.1 |
GO:1990839 |
response to endothelin(GO:1990839) |
| 0.5 |
0.5 |
GO:0070828 |
heterochromatin organization(GO:0070828) |
| 0.5 |
1.1 |
GO:0046121 |
deoxyribonucleoside catabolic process(GO:0046121) |
| 0.5 |
2.1 |
GO:0002484 |
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
| 0.5 |
1.1 |
GO:1903976 |
negative regulation of glial cell migration(GO:1903976) |
| 0.5 |
1.6 |
GO:0042938 |
dipeptide transport(GO:0042938) |
| 0.5 |
1.6 |
GO:0043267 |
negative regulation of potassium ion transport(GO:0043267) |
| 0.5 |
0.5 |
GO:0048861 |
leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.5 |
3.6 |
GO:0002318 |
myeloid progenitor cell differentiation(GO:0002318) |
| 0.5 |
1.6 |
GO:0072717 |
cellular response to actinomycin D(GO:0072717) |
| 0.5 |
8.8 |
GO:0045653 |
negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.5 |
1.0 |
GO:1903377 |
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.5 |
3.1 |
GO:0071229 |
cellular response to acid chemical(GO:0071229) |
| 0.5 |
1.0 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 0.5 |
4.1 |
GO:0031274 |
positive regulation of pseudopodium assembly(GO:0031274) |
| 0.5 |
1.5 |
GO:0098968 |
neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
| 0.5 |
2.6 |
GO:0051461 |
regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
| 0.5 |
2.0 |
GO:0006529 |
asparagine biosynthetic process(GO:0006529) |
| 0.5 |
1.0 |
GO:1902498 |
regulation of protein autoubiquitination(GO:1902498) |
| 0.5 |
0.5 |
GO:0010764 |
negative regulation of fibroblast migration(GO:0010764) |
| 0.5 |
2.5 |
GO:0090209 |
negative regulation of triglyceride metabolic process(GO:0090209) |
| 0.5 |
4.5 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.5 |
3.5 |
GO:0034508 |
centromere complex assembly(GO:0034508) |
| 0.5 |
3.5 |
GO:0061087 |
positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.5 |
3.5 |
GO:0042760 |
very long-chain fatty acid catabolic process(GO:0042760) |
| 0.5 |
2.0 |
GO:0032196 |
regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) transposition(GO:0032196) |
| 0.5 |
1.5 |
GO:0006338 |
chromatin remodeling(GO:0006338) |
| 0.5 |
1.5 |
GO:0051933 |
amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
| 0.5 |
2.0 |
GO:0036151 |
phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.5 |
1.9 |
GO:0038065 |
collagen-activated signaling pathway(GO:0038065) |
| 0.5 |
4.8 |
GO:2000653 |
regulation of genetic imprinting(GO:2000653) |
| 0.5 |
0.5 |
GO:0035905 |
ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
| 0.5 |
2.9 |
GO:0038166 |
angiotensin-activated signaling pathway(GO:0038166) |
| 0.5 |
1.9 |
GO:0030214 |
hyaluronan catabolic process(GO:0030214) |
| 0.5 |
3.3 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.5 |
0.5 |
GO:0002331 |
pre-B cell allelic exclusion(GO:0002331) |
| 0.5 |
0.5 |
GO:0048144 |
fibroblast proliferation(GO:0048144) |
| 0.5 |
1.4 |
GO:0046133 |
pyrimidine ribonucleoside catabolic process(GO:0046133) |
| 0.5 |
1.4 |
GO:0072139 |
glomerular parietal epithelial cell differentiation(GO:0072139) positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
| 0.5 |
1.4 |
GO:0042743 |
hydrogen peroxide metabolic process(GO:0042743) |
| 0.5 |
4.2 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.5 |
0.9 |
GO:2000416 |
regulation of eosinophil migration(GO:2000416) positive regulation of eosinophil migration(GO:2000418) |
| 0.5 |
3.2 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.5 |
0.9 |
GO:0071649 |
chemokine (C-C motif) ligand 5 production(GO:0071609) regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
| 0.5 |
0.9 |
GO:0014063 |
negative regulation of serotonin secretion(GO:0014063) |
| 0.5 |
6.4 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.5 |
0.9 |
GO:0060686 |
negative regulation of prostatic bud formation(GO:0060686) |
| 0.5 |
1.4 |
GO:0014835 |
myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 0.5 |
2.3 |
GO:0032493 |
response to bacterial lipoprotein(GO:0032493) |
| 0.5 |
1.4 |
GO:0019065 |
receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.5 |
1.4 |
GO:0097154 |
GABAergic neuron differentiation(GO:0097154) |
| 0.5 |
0.9 |
GO:0033030 |
negative regulation of neutrophil apoptotic process(GO:0033030) |
| 0.5 |
0.5 |
GO:1905076 |
regulation of interleukin-17 secretion(GO:1905076) |
| 0.5 |
8.2 |
GO:0045662 |
negative regulation of myoblast differentiation(GO:0045662) |
| 0.5 |
1.8 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.5 |
16.3 |
GO:2000134 |
negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
| 0.4 |
0.9 |
GO:0000454 |
snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
| 0.4 |
0.9 |
GO:0072718 |
response to cisplatin(GO:0072718) |
| 0.4 |
1.8 |
GO:0090261 |
positive regulation of inclusion body assembly(GO:0090261) |
| 0.4 |
3.1 |
GO:0003084 |
positive regulation of systemic arterial blood pressure(GO:0003084) |
| 0.4 |
3.1 |
GO:0030206 |
chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.4 |
4.0 |
GO:0032494 |
response to peptidoglycan(GO:0032494) |
| 0.4 |
0.9 |
GO:0016340 |
calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.4 |
0.4 |
GO:0050858 |
negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) |
| 0.4 |
1.3 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.4 |
3.1 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.4 |
2.2 |
GO:0040032 |
post-embryonic body morphogenesis(GO:0040032) |
| 0.4 |
1.3 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
| 0.4 |
0.4 |
GO:0061368 |
behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
| 0.4 |
2.2 |
GO:1903215 |
negative regulation of protein targeting to mitochondrion(GO:1903215) |
| 0.4 |
6.9 |
GO:0031987 |
locomotion involved in locomotory behavior(GO:0031987) |
| 0.4 |
0.4 |
GO:0007006 |
mitochondrial membrane organization(GO:0007006) |
| 0.4 |
0.4 |
GO:1902109 |
negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
| 0.4 |
1.7 |
GO:0070537 |
histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.4 |
1.3 |
GO:0021511 |
spinal cord patterning(GO:0021511) |
| 0.4 |
0.4 |
GO:0070837 |
dehydroascorbic acid transport(GO:0070837) |
| 0.4 |
3.8 |
GO:1902416 |
positive regulation of mRNA binding(GO:1902416) |
| 0.4 |
0.4 |
GO:0048021 |
regulation of secondary metabolic process(GO:0043455) regulation of melanin biosynthetic process(GO:0048021) regulation of secondary metabolite biosynthetic process(GO:1900376) |
| 0.4 |
1.7 |
GO:0002175 |
protein localization to paranode region of axon(GO:0002175) |
| 0.4 |
1.7 |
GO:0061308 |
cardiac neural crest cell development involved in heart development(GO:0061308) |
| 0.4 |
1.3 |
GO:0070601 |
centromeric sister chromatid cohesion(GO:0070601) |
| 0.4 |
2.9 |
GO:0048742 |
regulation of skeletal muscle fiber development(GO:0048742) |
| 0.4 |
1.2 |
GO:1903416 |
response to glycoside(GO:1903416) |
| 0.4 |
1.6 |
GO:0046469 |
platelet activating factor metabolic process(GO:0046469) |
| 0.4 |
2.0 |
GO:0048133 |
germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 0.4 |
0.4 |
GO:0033603 |
positive regulation of dopamine secretion(GO:0033603) |
| 0.4 |
2.5 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.4 |
1.6 |
GO:0055099 |
response to high density lipoprotein particle(GO:0055099) |
| 0.4 |
1.2 |
GO:0006742 |
NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.4 |
2.0 |
GO:0036006 |
response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
| 0.4 |
1.6 |
GO:0000415 |
negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.4 |
6.1 |
GO:0001913 |
T cell mediated cytotoxicity(GO:0001913) |
| 0.4 |
0.8 |
GO:2000383 |
regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
| 0.4 |
2.8 |
GO:0032596 |
protein transport into membrane raft(GO:0032596) |
| 0.4 |
0.4 |
GO:0072076 |
nephrogenic mesenchyme development(GO:0072076) pattern specification involved in metanephros development(GO:0072268) |
| 0.4 |
1.2 |
GO:1904211 |
membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.4 |
1.2 |
GO:0097070 |
ductus arteriosus closure(GO:0097070) |
| 0.4 |
1.6 |
GO:0010519 |
negative regulation of phospholipase activity(GO:0010519) |
| 0.4 |
3.5 |
GO:0008105 |
asymmetric protein localization(GO:0008105) |
| 0.4 |
0.8 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.4 |
2.7 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.4 |
7.0 |
GO:1902857 |
positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.4 |
2.7 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.4 |
1.5 |
GO:0090103 |
cochlea morphogenesis(GO:0090103) |
| 0.4 |
4.6 |
GO:0030220 |
platelet formation(GO:0030220) |
| 0.4 |
1.5 |
GO:2000051 |
negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.4 |
0.8 |
GO:0032286 |
central nervous system myelin maintenance(GO:0032286) |
| 0.4 |
2.3 |
GO:0030953 |
astral microtubule organization(GO:0030953) |
| 0.4 |
5.3 |
GO:0046597 |
negative regulation of viral entry into host cell(GO:0046597) |
| 0.4 |
2.6 |
GO:0006729 |
tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.4 |
0.8 |
GO:0042421 |
norepinephrine biosynthetic process(GO:0042421) |
| 0.4 |
1.1 |
GO:0007520 |
myoblast fusion(GO:0007520) |
| 0.4 |
1.5 |
GO:0036297 |
interstrand cross-link repair(GO:0036297) |
| 0.4 |
0.7 |
GO:1902807 |
negative regulation of cell cycle G1/S phase transition(GO:1902807) |
| 0.4 |
1.1 |
GO:0042538 |
hyperosmotic salinity response(GO:0042538) |
| 0.4 |
3.7 |
GO:0046051 |
UTP metabolic process(GO:0046051) |
| 0.4 |
0.4 |
GO:0002934 |
desmosome organization(GO:0002934) regulation of keratinocyte differentiation(GO:0045616) |
| 0.4 |
3.7 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.4 |
1.1 |
GO:0071947 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.4 |
2.6 |
GO:0031100 |
organ regeneration(GO:0031100) |
| 0.4 |
1.1 |
GO:1901675 |
response to methylglyoxal(GO:0051595) negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 0.4 |
0.4 |
GO:0031440 |
regulation of mRNA 3'-end processing(GO:0031440) |
| 0.4 |
1.8 |
GO:0048546 |
digestive tract morphogenesis(GO:0048546) |
| 0.4 |
2.5 |
GO:0043201 |
response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
| 0.4 |
0.4 |
GO:0090241 |
negative regulation of histone H4 acetylation(GO:0090241) |
| 0.4 |
1.4 |
GO:0006526 |
arginine biosynthetic process(GO:0006526) |
| 0.4 |
7.2 |
GO:0035411 |
catenin import into nucleus(GO:0035411) |
| 0.4 |
0.4 |
GO:0072734 |
response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.4 |
2.1 |
GO:0042219 |
cellular modified amino acid catabolic process(GO:0042219) |
| 0.4 |
0.7 |
GO:0019511 |
peptidyl-proline hydroxylation(GO:0019511) |
| 0.4 |
0.4 |
GO:0042095 |
interferon-gamma biosynthetic process(GO:0042095) |
| 0.4 |
1.8 |
GO:0010606 |
positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.4 |
0.7 |
GO:0051105 |
regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
| 0.4 |
1.8 |
GO:0019471 |
4-hydroxyproline metabolic process(GO:0019471) |
| 0.3 |
3.8 |
GO:2000001 |
regulation of DNA damage checkpoint(GO:2000001) |
| 0.3 |
4.4 |
GO:0006388 |
tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.3 |
1.4 |
GO:0033499 |
galactose catabolic process via UDP-galactose(GO:0033499) |
| 0.3 |
3.4 |
GO:0001658 |
branching involved in ureteric bud morphogenesis(GO:0001658) mesonephric tubule morphogenesis(GO:0072171) |
| 0.3 |
0.7 |
GO:1903719 |
regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.3 |
1.7 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.3 |
1.0 |
GO:0010814 |
neuropeptide catabolic process(GO:0010813) substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.3 |
0.7 |
GO:0046475 |
glycerophospholipid catabolic process(GO:0046475) |
| 0.3 |
1.0 |
GO:0048255 |
mRNA stabilization(GO:0048255) |
| 0.3 |
0.3 |
GO:0010635 |
regulation of mitochondrial fusion(GO:0010635) negative regulation of mitochondrial fusion(GO:0010637) |
| 0.3 |
1.6 |
GO:0043403 |
skeletal muscle tissue regeneration(GO:0043403) |
| 0.3 |
3.3 |
GO:0006337 |
nucleosome disassembly(GO:0006337) |
| 0.3 |
0.7 |
GO:0018195 |
peptidyl-arginine modification(GO:0018195) |
| 0.3 |
1.6 |
GO:0002862 |
negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.3 |
4.5 |
GO:2000574 |
regulation of microtubule motor activity(GO:2000574) |
| 0.3 |
1.3 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.3 |
2.6 |
GO:0032369 |
negative regulation of lipid transport(GO:0032369) |
| 0.3 |
3.2 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 0.3 |
3.5 |
GO:0021516 |
dorsal spinal cord development(GO:0021516) |
| 0.3 |
1.0 |
GO:1902310 |
positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 0.3 |
0.6 |
GO:0031660 |
regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) |
| 0.3 |
1.6 |
GO:0015822 |
ornithine transport(GO:0015822) |
| 0.3 |
0.3 |
GO:1990379 |
lipid transport across blood brain barrier(GO:1990379) |
| 0.3 |
2.5 |
GO:0035437 |
maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.3 |
0.6 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.3 |
0.9 |
GO:0046016 |
regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) |
| 0.3 |
3.8 |
GO:0036342 |
post-anal tail morphogenesis(GO:0036342) |
| 0.3 |
0.9 |
GO:0050691 |
regulation of defense response to virus by host(GO:0050691) |
| 0.3 |
0.3 |
GO:0050891 |
multicellular organismal water homeostasis(GO:0050891) establishment of skin barrier(GO:0061436) |
| 0.3 |
0.3 |
GO:0060971 |
embryonic heart tube left/right pattern formation(GO:0060971) |
| 0.3 |
2.8 |
GO:0006924 |
activation-induced cell death of T cells(GO:0006924) |
| 0.3 |
3.1 |
GO:0048535 |
lymph node development(GO:0048535) |
| 0.3 |
0.6 |
GO:0046686 |
response to cadmium ion(GO:0046686) |
| 0.3 |
0.9 |
GO:2000858 |
mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) positive regulation of mineralocorticoid secretion(GO:2000857) regulation of aldosterone secretion(GO:2000858) positive regulation of aldosterone secretion(GO:2000860) |
| 0.3 |
1.5 |
GO:0018002 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.3 |
1.8 |
GO:0019885 |
antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 0.3 |
2.1 |
GO:0045003 |
DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.3 |
0.6 |
GO:1903334 |
positive regulation of protein folding(GO:1903334) |
| 0.3 |
7.6 |
GO:0009649 |
entrainment of circadian clock(GO:0009649) |
| 0.3 |
0.9 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.3 |
0.6 |
GO:0048875 |
chemical homeostasis within a tissue(GO:0048875) |
| 0.3 |
0.9 |
GO:0060536 |
cartilage morphogenesis(GO:0060536) |
| 0.3 |
3.6 |
GO:0000183 |
chromatin silencing at rDNA(GO:0000183) |
| 0.3 |
5.7 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.3 |
3.3 |
GO:0010574 |
regulation of vascular endothelial growth factor production(GO:0010574) |
| 0.3 |
0.6 |
GO:1902071 |
regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
| 0.3 |
1.2 |
GO:0046909 |
intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.3 |
0.3 |
GO:0014016 |
neuroblast differentiation(GO:0014016) |
| 0.3 |
2.9 |
GO:0045930 |
negative regulation of mitotic cell cycle(GO:0045930) |
| 0.3 |
1.5 |
GO:0035563 |
positive regulation of chromatin binding(GO:0035563) |
| 0.3 |
2.3 |
GO:0034377 |
plasma lipoprotein particle assembly(GO:0034377) |
| 0.3 |
1.7 |
GO:0070206 |
protein trimerization(GO:0070206) |
| 0.3 |
2.9 |
GO:0043555 |
regulation of translation in response to stress(GO:0043555) |
| 0.3 |
3.8 |
GO:0036065 |
fucosylation(GO:0036065) |
| 0.3 |
2.3 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 0.3 |
1.7 |
GO:0048873 |
homeostasis of number of cells within a tissue(GO:0048873) |
| 0.3 |
1.4 |
GO:1900038 |
negative regulation of cellular response to hypoxia(GO:1900038) |
| 0.3 |
0.9 |
GO:0061537 |
glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.3 |
1.1 |
GO:0006297 |
nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.3 |
7.4 |
GO:0045737 |
positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 0.3 |
1.4 |
GO:0015868 |
purine ribonucleotide transport(GO:0015868) |
| 0.3 |
1.1 |
GO:0015888 |
thiamine transport(GO:0015888) |
| 0.3 |
1.1 |
GO:1901673 |
regulation of mitotic spindle assembly(GO:1901673) |
| 0.3 |
0.3 |
GO:0036035 |
osteoclast development(GO:0036035) |
| 0.3 |
0.8 |
GO:1903026 |
negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
| 0.3 |
1.7 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.3 |
0.8 |
GO:0071372 |
response to follicle-stimulating hormone(GO:0032354) response to gonadotropin(GO:0034698) cellular response to gonadotropin stimulus(GO:0071371) cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
| 0.3 |
0.8 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.3 |
0.8 |
GO:0070476 |
rRNA (guanine-N7)-methylation(GO:0070476) |
| 0.3 |
0.3 |
GO:0070171 |
negative regulation of tooth mineralization(GO:0070171) |
| 0.3 |
1.1 |
GO:1900169 |
regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
| 0.3 |
3.0 |
GO:0045724 |
positive regulation of cilium assembly(GO:0045724) |
| 0.3 |
1.1 |
GO:0048754 |
branching morphogenesis of an epithelial tube(GO:0048754) |
| 0.3 |
1.4 |
GO:0044783 |
G1 DNA damage checkpoint(GO:0044783) |
| 0.3 |
2.4 |
GO:0098789 |
pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.3 |
0.5 |
GO:1990523 |
bone regeneration(GO:1990523) |
| 0.3 |
2.2 |
GO:0070816 |
phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.3 |
0.8 |
GO:0001978 |
regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) |
| 0.3 |
0.3 |
GO:0032472 |
Golgi calcium ion transport(GO:0032472) |
| 0.3 |
0.8 |
GO:0000098 |
sulfur amino acid catabolic process(GO:0000098) |
| 0.3 |
0.5 |
GO:0021983 |
pituitary gland development(GO:0021983) |
| 0.3 |
0.8 |
GO:0046600 |
negative regulation of centriole replication(GO:0046600) |
| 0.3 |
0.5 |
GO:0071482 |
cellular response to light stimulus(GO:0071482) |
| 0.3 |
0.3 |
GO:0002678 |
positive regulation of chronic inflammatory response(GO:0002678) |
| 0.3 |
1.3 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.3 |
0.5 |
GO:0051984 |
positive regulation of chromosome segregation(GO:0051984) |
| 0.3 |
0.8 |
GO:0048566 |
embryonic digestive tract development(GO:0048566) |
| 0.3 |
1.3 |
GO:0016479 |
negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
| 0.3 |
2.9 |
GO:1904293 |
negative regulation of ERAD pathway(GO:1904293) |
| 0.3 |
0.3 |
GO:1904760 |
myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) |
| 0.3 |
0.8 |
GO:1905050 |
positive regulation of metallopeptidase activity(GO:1905050) |
| 0.3 |
0.5 |
GO:0002329 |
pre-B cell differentiation(GO:0002329) |
| 0.3 |
0.5 |
GO:0097026 |
dendritic cell dendrite assembly(GO:0097026) |
| 0.3 |
2.3 |
GO:0045780 |
positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
| 0.3 |
0.8 |
GO:0090201 |
negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
| 0.3 |
0.5 |
GO:0010920 |
negative regulation of inositol phosphate biosynthetic process(GO:0010920) testosterone biosynthetic process(GO:0061370) regulation of testosterone biosynthetic process(GO:2000224) |
| 0.3 |
0.3 |
GO:0051901 |
positive regulation of mitochondrial depolarization(GO:0051901) |
| 0.3 |
0.8 |
GO:0006001 |
fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
| 0.3 |
1.3 |
GO:0006189 |
'de novo' IMP biosynthetic process(GO:0006189) |
| 0.3 |
3.3 |
GO:0000578 |
embryonic axis specification(GO:0000578) |
| 0.3 |
2.3 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.3 |
1.0 |
GO:2000811 |
negative regulation of anoikis(GO:2000811) |
| 0.2 |
4.5 |
GO:0010664 |
negative regulation of striated muscle cell apoptotic process(GO:0010664) |
| 0.2 |
1.7 |
GO:2000507 |
positive regulation of energy homeostasis(GO:2000507) |
| 0.2 |
0.7 |
GO:0034473 |
U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
| 0.2 |
0.5 |
GO:0016925 |
protein sumoylation(GO:0016925) |
| 0.2 |
0.7 |
GO:0030225 |
macrophage differentiation(GO:0030225) |
| 0.2 |
0.7 |
GO:2000435 |
regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
| 0.2 |
0.7 |
GO:0032682 |
negative regulation of chemokine production(GO:0032682) |
| 0.2 |
2.5 |
GO:0046548 |
retinal rod cell development(GO:0046548) |
| 0.2 |
9.2 |
GO:0070303 |
negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
| 0.2 |
0.7 |
GO:0006271 |
DNA strand elongation involved in DNA replication(GO:0006271) |
| 0.2 |
1.5 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.2 |
3.4 |
GO:0006516 |
glycoprotein catabolic process(GO:0006516) |
| 0.2 |
0.5 |
GO:0070782 |
phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
| 0.2 |
0.5 |
GO:1901857 |
positive regulation of cellular respiration(GO:1901857) |
| 0.2 |
0.2 |
GO:0036344 |
platelet morphogenesis(GO:0036344) |
| 0.2 |
2.9 |
GO:0009437 |
amino-acid betaine metabolic process(GO:0006577) carnitine metabolic process(GO:0009437) |
| 0.2 |
0.5 |
GO:0033690 |
positive regulation of osteoblast proliferation(GO:0033690) |
| 0.2 |
0.7 |
GO:0043950 |
positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.2 |
1.7 |
GO:0070475 |
rRNA base methylation(GO:0070475) |
| 0.2 |
1.7 |
GO:0009954 |
proximal/distal pattern formation(GO:0009954) |
| 0.2 |
6.5 |
GO:0021591 |
ventricular system development(GO:0021591) |
| 0.2 |
0.7 |
GO:0033182 |
regulation of histone ubiquitination(GO:0033182) |
| 0.2 |
11.4 |
GO:0006261 |
DNA-dependent DNA replication(GO:0006261) |
| 0.2 |
0.5 |
GO:0021871 |
forebrain regionalization(GO:0021871) |
| 0.2 |
4.8 |
GO:0010390 |
histone monoubiquitination(GO:0010390) |
| 0.2 |
2.1 |
GO:0001833 |
inner cell mass cell proliferation(GO:0001833) |
| 0.2 |
1.6 |
GO:0007064 |
mitotic sister chromatid cohesion(GO:0007064) |
| 0.2 |
0.5 |
GO:1901642 |
purine nucleoside transmembrane transport(GO:0015860) nucleoside transmembrane transport(GO:1901642) |
| 0.2 |
0.9 |
GO:0070233 |
negative regulation of T cell apoptotic process(GO:0070233) |
| 0.2 |
0.7 |
GO:0031204 |
posttranslational protein targeting to membrane, translocation(GO:0031204) |
| 0.2 |
1.6 |
GO:1901623 |
regulation of lymphocyte chemotaxis(GO:1901623) |
| 0.2 |
0.2 |
GO:1904667 |
negative regulation of ubiquitin protein ligase activity(GO:1904667) |
| 0.2 |
3.9 |
GO:0045445 |
myoblast differentiation(GO:0045445) |
| 0.2 |
2.5 |
GO:0060441 |
epithelial tube branching involved in lung morphogenesis(GO:0060441) |
| 0.2 |
1.6 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.2 |
0.2 |
GO:0045779 |
negative regulation of bone resorption(GO:0045779) |
| 0.2 |
1.1 |
GO:0032927 |
positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.2 |
0.9 |
GO:0010826 |
negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
| 0.2 |
0.5 |
GO:0046125 |
pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.2 |
1.1 |
GO:0045948 |
positive regulation of translational initiation(GO:0045948) |
| 0.2 |
0.2 |
GO:0071921 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.2 |
0.9 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.2 |
1.1 |
GO:0044872 |
lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.2 |
1.1 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.2 |
21.5 |
GO:0051028 |
mRNA transport(GO:0051028) |
| 0.2 |
9.5 |
GO:0006342 |
chromatin silencing(GO:0006342) |
| 0.2 |
0.7 |
GO:0060011 |
Sertoli cell proliferation(GO:0060011) |
| 0.2 |
1.5 |
GO:1900017 |
positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.2 |
0.9 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 0.2 |
0.9 |
GO:0036265 |
RNA (guanine-N7)-methylation(GO:0036265) |
| 0.2 |
2.2 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.2 |
1.3 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.2 |
0.6 |
GO:0008635 |
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.2 |
0.4 |
GO:0060084 |
synaptic transmission involved in micturition(GO:0060084) |
| 0.2 |
0.2 |
GO:0035359 |
negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
| 0.2 |
0.9 |
GO:0007320 |
insemination(GO:0007320) |
| 0.2 |
1.5 |
GO:0007100 |
mitotic centrosome separation(GO:0007100) |
| 0.2 |
5.1 |
GO:0050873 |
brown fat cell differentiation(GO:0050873) |
| 0.2 |
1.7 |
GO:0032695 |
negative regulation of interleukin-12 production(GO:0032695) |
| 0.2 |
2.3 |
GO:0006353 |
DNA-templated transcription, termination(GO:0006353) |
| 0.2 |
0.2 |
GO:0019249 |
lactate biosynthetic process(GO:0019249) |
| 0.2 |
0.6 |
GO:0045742 |
positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
| 0.2 |
0.8 |
GO:0032488 |
Cdc42 protein signal transduction(GO:0032488) |
| 0.2 |
0.4 |
GO:0033484 |
nitric oxide homeostasis(GO:0033484) |
| 0.2 |
1.0 |
GO:0044375 |
regulation of peroxisome size(GO:0044375) |
| 0.2 |
0.4 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.2 |
0.4 |
GO:0097155 |
fasciculation of sensory neuron axon(GO:0097155) |
| 0.2 |
4.6 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.2 |
0.2 |
GO:0051132 |
NK T cell activation(GO:0051132) |
| 0.2 |
1.7 |
GO:0060766 |
negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 0.2 |
1.7 |
GO:0036119 |
response to platelet-derived growth factor(GO:0036119) |
| 0.2 |
0.4 |
GO:0033615 |
mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.2 |
0.8 |
GO:0098535 |
de novo centriole assembly(GO:0098535) |
| 0.2 |
0.8 |
GO:0010636 |
positive regulation of mitochondrial fusion(GO:0010636) |
| 0.2 |
1.2 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.2 |
0.4 |
GO:0036090 |
cleavage furrow ingression(GO:0036090) |
| 0.2 |
0.4 |
GO:0003161 |
cardiac conduction system development(GO:0003161) |
| 0.2 |
2.6 |
GO:1904355 |
positive regulation of telomere capping(GO:1904355) |
| 0.2 |
2.6 |
GO:1903845 |
negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
| 0.2 |
2.2 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.2 |
1.0 |
GO:0031468 |
nuclear envelope reassembly(GO:0031468) |
| 0.2 |
0.4 |
GO:0060012 |
synaptic transmission, glycinergic(GO:0060012) |
| 0.2 |
0.6 |
GO:2000312 |
regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.2 |
1.6 |
GO:0035994 |
response to muscle stretch(GO:0035994) |
| 0.2 |
9.9 |
GO:0006635 |
fatty acid beta-oxidation(GO:0006635) |
| 0.2 |
0.2 |
GO:0035092 |
spermatid nucleus differentiation(GO:0007289) sperm chromatin condensation(GO:0035092) |
| 0.2 |
0.6 |
GO:0043456 |
regulation of pentose-phosphate shunt(GO:0043456) |
| 0.2 |
0.2 |
GO:0090091 |
positive regulation of extracellular matrix disassembly(GO:0090091) |
| 0.2 |
2.9 |
GO:0015701 |
bicarbonate transport(GO:0015701) |
| 0.2 |
2.7 |
GO:0008589 |
regulation of smoothened signaling pathway(GO:0008589) |
| 0.2 |
1.4 |
GO:0045292 |
mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.2 |
5.4 |
GO:0006783 |
heme biosynthetic process(GO:0006783) |
| 0.2 |
0.2 |
GO:0019433 |
triglyceride catabolic process(GO:0019433) |
| 0.2 |
2.9 |
GO:0044381 |
glucose import in response to insulin stimulus(GO:0044381) regulation of glucose import in response to insulin stimulus(GO:2001273) |
| 0.2 |
5.0 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.2 |
1.0 |
GO:0090502 |
RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.2 |
0.4 |
GO:0035115 |
embryonic forelimb morphogenesis(GO:0035115) |
| 0.2 |
0.7 |
GO:0010510 |
regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
| 0.2 |
2.4 |
GO:0001937 |
negative regulation of endothelial cell proliferation(GO:0001937) |
| 0.2 |
0.7 |
GO:0045601 |
regulation of endothelial cell differentiation(GO:0045601) |
| 0.2 |
1.1 |
GO:0030035 |
microspike assembly(GO:0030035) |
| 0.2 |
1.1 |
GO:0032897 |
negative regulation of viral transcription(GO:0032897) |
| 0.2 |
4.7 |
GO:0015985 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.2 |
0.4 |
GO:1903774 |
positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.2 |
1.6 |
GO:0021846 |
cell proliferation in forebrain(GO:0021846) |
| 0.2 |
2.0 |
GO:0032957 |
inositol trisphosphate metabolic process(GO:0032957) |
| 0.2 |
0.7 |
GO:0071361 |
cellular response to ethanol(GO:0071361) |
| 0.2 |
0.5 |
GO:0006030 |
chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.2 |
2.0 |
GO:0032060 |
bleb assembly(GO:0032060) |
| 0.2 |
0.2 |
GO:0045577 |
regulation of B cell differentiation(GO:0045577) |
| 0.2 |
0.2 |
GO:0003091 |
renal water homeostasis(GO:0003091) |
| 0.2 |
0.4 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.2 |
0.4 |
GO:0000966 |
RNA 5'-end processing(GO:0000966) |
| 0.2 |
0.5 |
GO:0050862 |
positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.2 |
0.2 |
GO:1904154 |
positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.2 |
0.7 |
GO:0071294 |
cellular response to zinc ion(GO:0071294) |
| 0.2 |
1.0 |
GO:0060330 |
regulation of response to interferon-gamma(GO:0060330) |
| 0.2 |
0.3 |
GO:0035562 |
negative regulation of chromatin binding(GO:0035562) |
| 0.2 |
0.5 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.2 |
1.5 |
GO:0045048 |
protein insertion into ER membrane(GO:0045048) |
| 0.2 |
3.6 |
GO:0031572 |
G2 DNA damage checkpoint(GO:0031572) |
| 0.2 |
1.5 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.2 |
0.5 |
GO:0000076 |
DNA replication checkpoint(GO:0000076) |
| 0.2 |
0.5 |
GO:0048698 |
negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 0.2 |
0.2 |
GO:0000303 |
response to superoxide(GO:0000303) |
| 0.2 |
1.3 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.2 |
1.3 |
GO:0060159 |
regulation of dopamine receptor signaling pathway(GO:0060159) |
| 0.2 |
0.3 |
GO:0070966 |
nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.2 |
1.0 |
GO:0046599 |
regulation of centriole replication(GO:0046599) |
| 0.2 |
2.5 |
GO:0008608 |
attachment of spindle microtubules to kinetochore(GO:0008608) |
| 0.2 |
1.3 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.2 |
1.3 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.2 |
0.3 |
GO:0035095 |
behavioral response to nicotine(GO:0035095) |
| 0.2 |
2.4 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.2 |
0.8 |
GO:0000712 |
resolution of meiotic recombination intermediates(GO:0000712) |
| 0.2 |
1.0 |
GO:1902004 |
positive regulation of beta-amyloid formation(GO:1902004) |
| 0.2 |
0.2 |
GO:0046485 |
ether lipid metabolic process(GO:0046485) |
| 0.2 |
2.3 |
GO:0042347 |
negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.2 |
0.3 |
GO:0045086 |
positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
| 0.2 |
0.2 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.2 |
0.8 |
GO:0035358 |
regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035358) |
| 0.2 |
0.5 |
GO:0009202 |
deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
| 0.2 |
0.5 |
GO:0060907 |
positive regulation of macrophage cytokine production(GO:0060907) |
| 0.2 |
0.3 |
GO:0002827 |
positive regulation of T-helper 1 type immune response(GO:0002827) |
| 0.2 |
0.3 |
GO:0035790 |
platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
| 0.2 |
0.2 |
GO:0016540 |
protein autoprocessing(GO:0016540) |
| 0.2 |
0.9 |
GO:0048384 |
retinoic acid receptor signaling pathway(GO:0048384) |
| 0.2 |
0.3 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.2 |
4.4 |
GO:0006493 |
protein O-linked glycosylation(GO:0006493) |
| 0.2 |
0.6 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.2 |
0.3 |
GO:1903273 |
regulation of sodium ion export(GO:1903273) positive regulation of sodium ion export(GO:1903275) regulation of sodium ion export from cell(GO:1903276) positive regulation of sodium ion export from cell(GO:1903278) |
| 0.2 |
0.3 |
GO:0006014 |
D-ribose metabolic process(GO:0006014) |
| 0.2 |
0.3 |
GO:0060390 |
regulation of SMAD protein import into nucleus(GO:0060390) |
| 0.2 |
0.2 |
GO:0060753 |
regulation of mast cell chemotaxis(GO:0060753) |
| 0.2 |
0.5 |
GO:0060644 |
mammary gland epithelial cell differentiation(GO:0060644) |
| 0.2 |
2.4 |
GO:0045638 |
negative regulation of myeloid cell differentiation(GO:0045638) |
| 0.2 |
0.5 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
| 0.2 |
0.2 |
GO:0035701 |
hematopoietic stem cell migration(GO:0035701) |
| 0.2 |
1.2 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.1 |
4.3 |
GO:0034314 |
Arp2/3 complex-mediated actin nucleation(GO:0034314) |
| 0.1 |
1.3 |
GO:0006309 |
DNA catabolic process, endonucleolytic(GO:0000737) apoptotic DNA fragmentation(GO:0006309) |
| 0.1 |
0.3 |
GO:0006011 |
UDP-glucose metabolic process(GO:0006011) glucose 1-phosphate metabolic process(GO:0019255) |
| 0.1 |
0.1 |
GO:0001757 |
somite specification(GO:0001757) |
| 0.1 |
0.4 |
GO:0071985 |
multivesicular body sorting pathway(GO:0071985) |
| 0.1 |
0.1 |
GO:1903564 |
regulation of protein localization to cilium(GO:1903564) |
| 0.1 |
0.3 |
GO:0090237 |
regulation of arachidonic acid secretion(GO:0090237) positive regulation of arachidonic acid secretion(GO:0090238) |
| 0.1 |
0.3 |
GO:0045076 |
regulation of interleukin-2 biosynthetic process(GO:0045076) |
| 0.1 |
0.3 |
GO:0070535 |
histone H2A K63-linked ubiquitination(GO:0070535) |
| 0.1 |
2.6 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.1 |
0.3 |
GO:0000350 |
generation of catalytic spliceosome for second transesterification step(GO:0000350) |
| 0.1 |
0.8 |
GO:0098734 |
protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 0.1 |
0.4 |
GO:0070102 |
interleukin-6-mediated signaling pathway(GO:0070102) |
| 0.1 |
0.6 |
GO:1902047 |
polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.1 |
0.3 |
GO:0010986 |
positive regulation of lipoprotein particle clearance(GO:0010986) |
| 0.1 |
0.1 |
GO:0048496 |
maintenance of organ identity(GO:0048496) |
| 0.1 |
2.7 |
GO:0007519 |
skeletal muscle tissue development(GO:0007519) |
| 0.1 |
1.2 |
GO:0001682 |
tRNA 5'-leader removal(GO:0001682) |
| 0.1 |
3.3 |
GO:0043171 |
peptide catabolic process(GO:0043171) |
| 0.1 |
0.3 |
GO:0018171 |
peptidyl-cysteine oxidation(GO:0018171) |
| 0.1 |
1.8 |
GO:0010633 |
negative regulation of epithelial cell migration(GO:0010633) |
| 0.1 |
0.7 |
GO:0036337 |
Fas signaling pathway(GO:0036337) |
| 0.1 |
0.5 |
GO:0035752 |
lysosomal lumen pH elevation(GO:0035752) |
| 0.1 |
0.3 |
GO:0001946 |
lymphangiogenesis(GO:0001946) |
| 0.1 |
0.5 |
GO:0080111 |
DNA demethylation(GO:0080111) |
| 0.1 |
1.5 |
GO:0060008 |
Sertoli cell differentiation(GO:0060008) |
| 0.1 |
3.5 |
GO:0033209 |
tumor necrosis factor-mediated signaling pathway(GO:0033209) |
| 0.1 |
2.3 |
GO:0033235 |
positive regulation of protein sumoylation(GO:0033235) |
| 0.1 |
0.4 |
GO:0006515 |
misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
| 0.1 |
0.1 |
GO:1904751 |
positive regulation of protein localization to nucleolus(GO:1904751) |
| 0.1 |
0.3 |
GO:1904754 |
positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
| 0.1 |
0.7 |
GO:0006907 |
pinocytosis(GO:0006907) |
| 0.1 |
0.5 |
GO:2000059 |
negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
| 0.1 |
2.1 |
GO:0006379 |
mRNA cleavage(GO:0006379) |
| 0.1 |
0.4 |
GO:0060947 |
cardiac vascular smooth muscle cell differentiation(GO:0060947) |
| 0.1 |
0.4 |
GO:1902774 |
late endosome to lysosome transport(GO:1902774) |
| 0.1 |
0.2 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.1 |
0.6 |
GO:0043046 |
DNA methylation involved in gamete generation(GO:0043046) |
| 0.1 |
0.1 |
GO:0015813 |
L-glutamate transport(GO:0015813) |
| 0.1 |
0.4 |
GO:0031076 |
embryonic camera-type eye development(GO:0031076) |
| 0.1 |
0.2 |
GO:0000212 |
meiotic spindle organization(GO:0000212) |
| 0.1 |
0.2 |
GO:0003338 |
metanephros morphogenesis(GO:0003338) |
| 0.1 |
0.1 |
GO:1903960 |
negative regulation of anion channel activity(GO:0010360) negative regulation of anion transmembrane transport(GO:1903960) |
| 0.1 |
0.4 |
GO:0045006 |
DNA deamination(GO:0045006) |
| 0.1 |
0.2 |
GO:0002408 |
myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.1 |
0.5 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.1 |
9.7 |
GO:0008033 |
tRNA processing(GO:0008033) |
| 0.1 |
0.1 |
GO:0060800 |
regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.1 |
0.4 |
GO:0001826 |
inner cell mass cell differentiation(GO:0001826) |
| 0.1 |
0.1 |
GO:0071044 |
histone mRNA catabolic process(GO:0071044) |
| 0.1 |
0.4 |
GO:0060468 |
prevention of polyspermy(GO:0060468) |
| 0.1 |
0.2 |
GO:0035106 |
operant conditioning(GO:0035106) |
| 0.1 |
1.0 |
GO:0048701 |
embryonic cranial skeleton morphogenesis(GO:0048701) |
| 0.1 |
0.7 |
GO:0032202 |
telomere assembly(GO:0032202) |
| 0.1 |
0.9 |
GO:0046827 |
positive regulation of protein export from nucleus(GO:0046827) |
| 0.1 |
0.1 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 0.1 |
0.5 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.1 |
0.2 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.1 |
1.6 |
GO:0097150 |
neuronal stem cell population maintenance(GO:0097150) |
| 0.1 |
0.8 |
GO:0001947 |
heart looping(GO:0001947) |
| 0.1 |
0.6 |
GO:0006868 |
glutamine transport(GO:0006868) |
| 0.1 |
0.1 |
GO:0071677 |
positive regulation of mononuclear cell migration(GO:0071677) |
| 0.1 |
0.7 |
GO:1902916 |
positive regulation of protein polyubiquitination(GO:1902916) |
| 0.1 |
0.8 |
GO:0090435 |
protein localization to nuclear envelope(GO:0090435) |
| 0.1 |
0.3 |
GO:0051770 |
positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
| 0.1 |
1.8 |
GO:0000338 |
protein deneddylation(GO:0000338) |
| 0.1 |
0.2 |
GO:0035162 |
embryonic hemopoiesis(GO:0035162) |
| 0.1 |
0.2 |
GO:0006549 |
isoleucine metabolic process(GO:0006549) |
| 0.1 |
0.1 |
GO:2000313 |
fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
| 0.1 |
0.9 |
GO:0071802 |
negative regulation of podosome assembly(GO:0071802) |
| 0.1 |
2.1 |
GO:0046039 |
GTP metabolic process(GO:0046039) |
| 0.1 |
0.5 |
GO:0045900 |
negative regulation of translational elongation(GO:0045900) |
| 0.1 |
1.5 |
GO:2001238 |
positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
| 0.1 |
0.2 |
GO:0090005 |
negative regulation of Golgi to plasma membrane protein transport(GO:0042997) negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
| 0.1 |
0.5 |
GO:2000036 |
regulation of stem cell population maintenance(GO:2000036) |
| 0.1 |
0.1 |
GO:0030860 |
regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.1 |
1.1 |
GO:0034498 |
early endosome to Golgi transport(GO:0034498) |
| 0.1 |
0.5 |
GO:0031022 |
nuclear migration along microfilament(GO:0031022) |
| 0.1 |
0.2 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.1 |
0.4 |
GO:0090051 |
negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) negative regulation of sprouting angiogenesis(GO:1903671) |
| 0.1 |
0.7 |
GO:0039703 |
viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.1 |
0.1 |
GO:0045084 |
positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 0.1 |
0.4 |
GO:0070886 |
positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.1 |
0.2 |
GO:2000678 |
negative regulation of transcription regulatory region DNA binding(GO:2000678) |
| 0.1 |
0.6 |
GO:0032534 |
regulation of microvillus assembly(GO:0032534) |
| 0.1 |
0.3 |
GO:0098974 |
postsynaptic actin cytoskeleton organization(GO:0098974) |
| 0.1 |
0.3 |
GO:0071028 |
nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
| 0.1 |
0.1 |
GO:0043388 |
positive regulation of DNA binding(GO:0043388) |
| 0.1 |
0.1 |
GO:0045091 |
single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
| 0.1 |
0.1 |
GO:0061739 |
protein lipidation involved in autophagosome assembly(GO:0061739) |
| 0.1 |
0.2 |
GO:0035507 |
regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.1 |
1.8 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.1 |
0.6 |
GO:0043518 |
negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 0.1 |
1.7 |
GO:0051298 |
centrosome duplication(GO:0051298) |
| 0.1 |
0.6 |
GO:0014733 |
regulation of skeletal muscle adaptation(GO:0014733) |
| 0.1 |
0.3 |
GO:0042415 |
norepinephrine metabolic process(GO:0042415) |
| 0.1 |
0.4 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.1 |
2.1 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.1 |
0.2 |
GO:0070633 |
transepithelial transport(GO:0070633) |
| 0.1 |
0.4 |
GO:1902744 |
negative regulation of lamellipodium organization(GO:1902744) |
| 0.1 |
0.1 |
GO:0032365 |
intracellular lipid transport(GO:0032365) |
| 0.1 |
0.4 |
GO:0051409 |
response to nitrosative stress(GO:0051409) |
| 0.1 |
0.2 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.1 |
0.4 |
GO:0050909 |
sensory perception of taste(GO:0050909) |
| 0.1 |
0.4 |
GO:0032911 |
negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.1 |
0.3 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.1 |
0.3 |
GO:0006166 |
purine ribonucleoside salvage(GO:0006166) |
| 0.1 |
0.9 |
GO:0030901 |
midbrain development(GO:0030901) |
| 0.1 |
0.3 |
GO:0042275 |
error-free postreplication DNA repair(GO:0042275) |
| 0.1 |
0.4 |
GO:0045583 |
regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
| 0.1 |
0.3 |
GO:0051973 |
positive regulation of telomerase activity(GO:0051973) |
| 0.1 |
0.7 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.1 |
1.7 |
GO:0002474 |
antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
| 0.1 |
0.6 |
GO:0030242 |
pexophagy(GO:0030242) |
| 0.1 |
0.3 |
GO:0001736 |
establishment of planar polarity(GO:0001736) establishment of tissue polarity(GO:0007164) |
| 0.1 |
0.7 |
GO:0030049 |
muscle filament sliding(GO:0030049) |
| 0.1 |
0.5 |
GO:0071257 |
cellular response to electrical stimulus(GO:0071257) |
| 0.1 |
0.2 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.1 |
4.2 |
GO:0061077 |
chaperone-mediated protein folding(GO:0061077) |
| 0.1 |
0.6 |
GO:0006122 |
mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.1 |
2.3 |
GO:0003341 |
cilium movement(GO:0003341) |
| 0.1 |
0.2 |
GO:0035067 |
negative regulation of histone acetylation(GO:0035067) |
| 0.1 |
0.2 |
GO:0036480 |
neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
| 0.1 |
1.3 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.1 |
0.1 |
GO:0050855 |
regulation of B cell receptor signaling pathway(GO:0050855) |
| 0.1 |
0.2 |
GO:0044241 |
lipid digestion(GO:0044241) |
| 0.1 |
0.2 |
GO:0070863 |
positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.1 |
0.8 |
GO:0002227 |
innate immune response in mucosa(GO:0002227) |
| 0.1 |
0.5 |
GO:0007130 |
synaptonemal complex assembly(GO:0007130) |
| 0.1 |
0.5 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
| 0.1 |
0.1 |
GO:0002385 |
organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
| 0.1 |
0.8 |
GO:0009083 |
branched-chain amino acid catabolic process(GO:0009083) |
| 0.1 |
0.2 |
GO:1902235 |
regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
| 0.1 |
0.1 |
GO:0051771 |
negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
| 0.1 |
0.3 |
GO:0033580 |
protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
| 0.1 |
1.4 |
GO:0071479 |
cellular response to ionizing radiation(GO:0071479) |
| 0.1 |
0.2 |
GO:0010961 |
cellular magnesium ion homeostasis(GO:0010961) |
| 0.1 |
0.1 |
GO:1990776 |
cellular response to angiotensin(GO:1904385) response to angiotensin(GO:1990776) |
| 0.1 |
0.1 |
GO:0002538 |
arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
| 0.1 |
0.3 |
GO:0000054 |
ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
| 0.1 |
0.1 |
GO:0060706 |
cell differentiation involved in embryonic placenta development(GO:0060706) |
| 0.1 |
1.0 |
GO:0070527 |
platelet aggregation(GO:0070527) |
| 0.1 |
1.8 |
GO:0006289 |
nucleotide-excision repair(GO:0006289) |
| 0.1 |
0.3 |
GO:0016559 |
peroxisome fission(GO:0016559) |
| 0.1 |
1.4 |
GO:0007026 |
negative regulation of microtubule depolymerization(GO:0007026) |
| 0.1 |
0.9 |
GO:0006998 |
nuclear envelope organization(GO:0006998) |
| 0.1 |
0.5 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.1 |
0.1 |
GO:0007197 |
adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 0.1 |
0.4 |
GO:0030539 |
male genitalia development(GO:0030539) |
| 0.1 |
0.1 |
GO:2000642 |
negative regulation of vacuolar transport(GO:1903336) negative regulation of early endosome to late endosome transport(GO:2000642) |
| 0.1 |
0.6 |
GO:0034142 |
toll-like receptor 4 signaling pathway(GO:0034142) |
| 0.1 |
1.1 |
GO:0006368 |
transcription elongation from RNA polymerase II promoter(GO:0006368) |
| 0.1 |
0.4 |
GO:0045792 |
negative regulation of cell size(GO:0045792) |
| 0.1 |
0.3 |
GO:0000492 |
box C/D snoRNP assembly(GO:0000492) |
| 0.1 |
0.2 |
GO:0008298 |
intracellular mRNA localization(GO:0008298) |
| 0.1 |
1.9 |
GO:0051225 |
spindle assembly(GO:0051225) |
| 0.1 |
2.5 |
GO:0030490 |
maturation of SSU-rRNA(GO:0030490) |
| 0.1 |
0.5 |
GO:0090200 |
positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.1 |
0.3 |
GO:0050684 |
regulation of mRNA processing(GO:0050684) |
| 0.1 |
0.1 |
GO:1904749 |
regulation of protein localization to nucleolus(GO:1904749) |
| 0.1 |
0.6 |
GO:0044253 |
positive regulation of collagen metabolic process(GO:0010714) positive regulation of multicellular organismal metabolic process(GO:0044253) |
| 0.1 |
0.2 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 0.1 |
0.2 |
GO:0044030 |
regulation of DNA methylation(GO:0044030) |
| 0.1 |
2.5 |
GO:0006506 |
GPI anchor biosynthetic process(GO:0006506) |
| 0.1 |
1.1 |
GO:0045580 |
regulation of T cell differentiation(GO:0045580) |
| 0.1 |
0.3 |
GO:0046208 |
spermine catabolic process(GO:0046208) |
| 0.1 |
0.3 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.1 |
0.1 |
GO:0031062 |
positive regulation of histone methylation(GO:0031062) |
| 0.1 |
0.4 |
GO:0043249 |
erythrocyte maturation(GO:0043249) |
| 0.1 |
0.2 |
GO:0030224 |
monocyte differentiation(GO:0030224) |
| 0.1 |
0.7 |
GO:0030514 |
negative regulation of BMP signaling pathway(GO:0030514) |
| 0.1 |
0.1 |
GO:0015819 |
lysine transport(GO:0015819) |
| 0.1 |
0.4 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.1 |
0.9 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.1 |
0.2 |
GO:0060177 |
regulation of angiotensin metabolic process(GO:0060177) |
| 0.1 |
0.9 |
GO:0071594 |
T cell differentiation in thymus(GO:0033077) thymocyte aggregation(GO:0071594) |
| 0.1 |
0.2 |
GO:0070232 |
regulation of T cell apoptotic process(GO:0070232) |
| 0.1 |
0.3 |
GO:0042438 |
melanin biosynthetic process(GO:0042438) secondary metabolite biosynthetic process(GO:0044550) pigment biosynthetic process(GO:0046148) |
| 0.1 |
0.2 |
GO:1902018 |
negative regulation of cilium assembly(GO:1902018) |
| 0.1 |
0.1 |
GO:0001575 |
globoside metabolic process(GO:0001575) |
| 0.1 |
0.4 |
GO:0035542 |
regulation of SNARE complex assembly(GO:0035542) |
| 0.1 |
0.2 |
GO:0070508 |
sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.1 |
0.3 |
GO:0043649 |
dicarboxylic acid catabolic process(GO:0043649) |
| 0.1 |
0.1 |
GO:0097494 |
regulation of vesicle size(GO:0097494) |
| 0.1 |
0.7 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.1 |
0.7 |
GO:0030574 |
collagen catabolic process(GO:0030574) |
| 0.1 |
0.2 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.1 |
1.3 |
GO:0006911 |
phagocytosis, engulfment(GO:0006911) |
| 0.1 |
0.5 |
GO:0043631 |
RNA polyadenylation(GO:0043631) |
| 0.1 |
2.1 |
GO:0002181 |
cytoplasmic translation(GO:0002181) |
| 0.1 |
0.9 |
GO:0046661 |
male sex differentiation(GO:0046661) |
| 0.1 |
0.3 |
GO:2000353 |
positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.0 |
0.7 |
GO:0006767 |
water-soluble vitamin metabolic process(GO:0006767) |
| 0.0 |
0.4 |
GO:0035090 |
maintenance of apical/basal cell polarity(GO:0035090) |
| 0.0 |
0.1 |
GO:0070574 |
cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.0 |
0.0 |
GO:0060405 |
regulation of penile erection(GO:0060405) |
| 0.0 |
0.2 |
GO:1904715 |
negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.0 |
0.2 |
GO:0043535 |
regulation of blood vessel endothelial cell migration(GO:0043535) |
| 0.0 |
0.1 |
GO:0030043 |
actin filament fragmentation(GO:0030043) |
| 0.0 |
0.0 |
GO:0045058 |
T cell selection(GO:0045058) |
| 0.0 |
0.1 |
GO:2000189 |
positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.0 |
0.1 |
GO:0002374 |
cytokine secretion involved in immune response(GO:0002374) regulation of cytokine secretion involved in immune response(GO:0002739) positive regulation of cytokine secretion involved in immune response(GO:0002741) |
| 0.0 |
0.2 |
GO:0003416 |
endochondral bone growth(GO:0003416) growth plate cartilage development(GO:0003417) |
| 0.0 |
0.0 |
GO:1902668 |
negative regulation of axon guidance(GO:1902668) |
| 0.0 |
0.5 |
GO:2000144 |
positive regulation of DNA-templated transcription, initiation(GO:2000144) |
| 0.0 |
0.0 |
GO:0019731 |
antibacterial humoral response(GO:0019731) |
| 0.0 |
0.3 |
GO:0097428 |
protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.0 |
0.3 |
GO:0009249 |
protein lipoylation(GO:0009249) |
| 0.0 |
0.9 |
GO:0030838 |
positive regulation of actin filament polymerization(GO:0030838) |
| 0.0 |
0.1 |
GO:0046462 |
monoacylglycerol metabolic process(GO:0046462) |
| 0.0 |
0.1 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.0 |
0.5 |
GO:2000179 |
positive regulation of neural precursor cell proliferation(GO:2000179) |
| 0.0 |
0.2 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.0 |
0.2 |
GO:0006451 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.0 |
0.2 |
GO:0042246 |
tissue regeneration(GO:0042246) |
| 0.0 |
0.2 |
GO:0032049 |
cardiolipin biosynthetic process(GO:0032049) |
| 0.0 |
0.0 |
GO:0033522 |
histone H2A ubiquitination(GO:0033522) |
| 0.0 |
0.1 |
GO:0048286 |
lung alveolus development(GO:0048286) |
| 0.0 |
0.3 |
GO:0032088 |
negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
| 0.0 |
0.1 |
GO:0032415 |
regulation of sodium:proton antiporter activity(GO:0032415) positive regulation of sodium:proton antiporter activity(GO:0032417) |
| 0.0 |
0.1 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 0.0 |
0.0 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.0 |
0.0 |
GO:0035582 |
sequestering of BMP in extracellular matrix(GO:0035582) |
| 0.0 |
0.1 |
GO:0046040 |
IMP metabolic process(GO:0046040) |
| 0.0 |
0.4 |
GO:0060746 |
parental behavior(GO:0060746) |
| 0.0 |
0.0 |
GO:0045646 |
regulation of erythrocyte differentiation(GO:0045646) |
| 0.0 |
0.1 |
GO:0070301 |
cellular response to hydrogen peroxide(GO:0070301) |
| 0.0 |
8.5 |
GO:0008380 |
RNA splicing(GO:0008380) |
| 0.0 |
0.3 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.0 |
1.5 |
GO:0006413 |
translational initiation(GO:0006413) |
| 0.0 |
0.2 |
GO:0006107 |
oxaloacetate metabolic process(GO:0006107) |
| 0.0 |
0.1 |
GO:0034331 |
cell junction maintenance(GO:0034331) |
| 0.0 |
0.1 |
GO:0009838 |
abscission(GO:0009838) |
| 0.0 |
0.1 |
GO:0043489 |
RNA stabilization(GO:0043489) |
| 0.0 |
0.3 |
GO:1900027 |
regulation of ruffle assembly(GO:1900027) |
| 0.0 |
0.1 |
GO:1902166 |
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
| 0.0 |
0.1 |
GO:0035826 |
rubidium ion transport(GO:0035826) |
| 0.0 |
0.1 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.0 |
0.2 |
GO:0045070 |
positive regulation of viral genome replication(GO:0045070) |
| 0.0 |
0.1 |
GO:0043090 |
amino acid import(GO:0043090) |
| 0.0 |
0.2 |
GO:0006739 |
NADP metabolic process(GO:0006739) |
| 0.0 |
0.1 |
GO:0006409 |
tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.0 |
0.2 |
GO:1901988 |
negative regulation of cell cycle phase transition(GO:1901988) |
| 0.0 |
0.2 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
| 0.0 |
0.0 |
GO:0002690 |
positive regulation of leukocyte chemotaxis(GO:0002690) |
| 0.0 |
0.2 |
GO:0051156 |
glucose 6-phosphate metabolic process(GO:0051156) |
| 0.0 |
0.1 |
GO:0038032 |
termination of G-protein coupled receptor signaling pathway(GO:0038032) |
| 0.0 |
0.0 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 0.0 |
0.2 |
GO:0009299 |
mRNA transcription(GO:0009299) |
| 0.0 |
0.0 |
GO:0006307 |
DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.0 |
0.1 |
GO:0051457 |
maintenance of protein location in nucleus(GO:0051457) |
| 0.0 |
0.0 |
GO:0042100 |
B cell proliferation(GO:0042100) |
| 0.0 |
0.6 |
GO:0045727 |
positive regulation of translation(GO:0045727) |
| 0.0 |
0.0 |
GO:0001887 |
selenium compound metabolic process(GO:0001887) selenocysteine metabolic process(GO:0016259) |
| 0.0 |
0.1 |
GO:2000616 |
negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 0.0 |
0.2 |
GO:2000637 |
positive regulation of gene silencing by miRNA(GO:2000637) |
| 0.0 |
0.0 |
GO:1902177 |
positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
| 0.0 |
0.1 |
GO:0006000 |
fructose metabolic process(GO:0006000) |
| 0.0 |
0.6 |
GO:0097031 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.0 |
0.2 |
GO:0030970 |
retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.0 |
0.1 |
GO:0071300 |
cellular response to retinoic acid(GO:0071300) |
| 0.0 |
0.1 |
GO:0031145 |
anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 0.0 |
0.1 |
GO:0042775 |
mitochondrial ATP synthesis coupled electron transport(GO:0042775) |
| 0.0 |
0.1 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.0 |
0.1 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.0 |
0.1 |
GO:0032462 |
regulation of protein homooligomerization(GO:0032462) |
| 0.0 |
0.0 |
GO:0060056 |
mammary gland involution(GO:0060056) |
| 0.0 |
0.0 |
GO:0038018 |
Wnt receptor catabolic process(GO:0038018) |
| 0.0 |
0.1 |
GO:0009650 |
UV protection(GO:0009650) |
| 0.0 |
0.0 |
GO:0001771 |
immunological synapse formation(GO:0001771) |
| 0.0 |
0.1 |
GO:0031018 |
endocrine pancreas development(GO:0031018) |
| 0.0 |
0.0 |
GO:0060575 |
intestinal epithelial cell differentiation(GO:0060575) |
| 0.0 |
0.0 |
GO:0006027 |
glycosaminoglycan catabolic process(GO:0006027) |
| 0.0 |
0.1 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 0.0 |
0.0 |
GO:0045040 |
protein import into mitochondrial outer membrane(GO:0045040) |
| 0.0 |
0.1 |
GO:0070458 |
detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
| 0.0 |
0.0 |
GO:0018214 |
peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |